The company's annual advanced appraisal has a new change.
Release time:
2020-08-14
tilts to the grassroots on performance appraisal
company's annual advanced appraisal has a new change
report near the end of the year, the group company's annual advanced appraisal work is also about to start. The reporter learned from the group office meeting that compared with previous years, the selection scope, standards and awards of some honors have changed. In the year of
2017 , the company will select 18 advanced collectives, namely 2 advanced enterprises, 2 advanced party organizations, 5 advanced civilized workshops (departments and offices), 8 advanced civilized teams and 1 advanced trade union organizations; outstanding individuals 25 are outstanding employees 10 , innovation experts 6 , outstanding management workers 3 and outstanding salesmen 6 respectively. Advanced individual 15 , they are advanced party workers 1 , outstanding communist party members 5 , advanced trade union workers 2 , trade union activists 2 , advanced safety and environmental protection workers 5 , and rookie employees 5 . By comparison, we can find that the previous "excellent scientific and technological workers" were replaced by "innovative experts", and the number of places increased from 3 to 6 . The number of "excellent salesmen" increased from 4 to 6 ; The number of "rookie employees" set for the first time in 2016 has also increased from 3 to 5 .
In addition to the changes in the name and number of honors, the selection criteria for some honors have also been adjusted accordingly. For example, the evaluation conditions of "excellent employees" emphasize "grass-roots employees with outstanding achievements and contributions in this year's work"; compared with the original "excellent scientific and technological workers", the evaluation conditions of "innovative experts" emphasize "innovative spirit, actively put forward reasonable suggestions, innovative plans or new methods, optimize processes and operation methods, etc, in the unit's technological transformation, product research and development, quality control, energy saving and consumption reduction, the application of new technologies and new methods, it has played a leading role and achieved more obvious results". It is understood that the reason for the above adjustment is that the company hopes that personal honor will be further tilted to the grassroots level, more front-line employees with outstanding performance will be introduced, and an example will be set around employees, so as to better create a working atmosphere for excellence and strive for the first place, so as to drive the majority of employees to actively participate in their work and promote the innovation and development of enterprises. This year's appraisal conditions further emphasize "within this year", also in order to avoid the phenomenon of "sitting in rows, dividing the fruits" and "taking turns to do it in advance, and coming to my home next year", using annual work performance to strengthen the effect of immediate incentives.
In addition, this year is the second selection of "rookie employees". The evaluation conditions for this honor include "employees who have previously won the honor of" rookie employees "will no longer participate in this selection", and the corresponding increase in the number of places is due to the consideration of encouraging new employees and discovering new talents on a larger scale. (Reporter Fu Yiwu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page